SkyePharma to Cut Jobs in Switzerland

SkyePharma has signed agreements with the Aenova Group to sub-let part of the laboratory space in Muttenz and has agreed to consider offering positions to some of the SkyePharma staff affected by the job cuts.

British drug delivery specialist SkyePharma plans to cut its workforce in Muttenz by 20% to improve competitiveness and generate CHF2.6m (￡1.8m) of operating cost savings each year.

Separately, the Group has entered into agreements with the Aenova Group to sub-let part of the laboratory space in Muttenz and sell some of the surplus laboratory equipment to the German manufacturer of solid oral dosage forms.

Aenova plans to use the space to expand its own non-competing oral product development activities and has agreed to consider offering positions to some of the SkyePharma staff affected by the job cuts.

The firm intends to make greater use of third-party sub-contracting for certain aspec